Basic Information | Post buying leads | Suppliers |
Name |
Beryllium hydrogen phosphate (1:1) |
EINECS | N/A |
CAS No. | 13598-15-7 | Density | g/cm3 |
PSA | 93.23000 | LogP | -0.05220 |
Solubility | insoluble H2O | Melting Point |
N/A |
Formula | BeHO4P | Boiling Point | 158°Cat760mmHg |
Molecular Weight | 104.99 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | Confirmed carcinogen with experimental carcinogenic and tumorigenic data. Poison by intravenous route. See also BERYLLIUM COMPOUNDS and PHOSPHATES. When heated to decomposition it emits very toxic fumes of BeO and POx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | 3 | |
Synonyms |
BERYLLIUM PHOSPHATE;berylliumhydrogenphosphate(1:1);berylliumphosphate(behpo4);phosphoricacid,berylliumsalt(1:1) |
IUPAC Name: beryllium hydrogen phosphate
Synonyms of Beryllium hydrogen phosphate (1:1) (CAS NO.13598-15-7): Beryllium phosphate (BeHPO4) ; HSDB 348 ; Phosphoric acid, beryllium salt (1:1) ; Phosphorous acid, beryllium salt ; Beryllium hydrogen phosphate (1:1) ; Beryllium phosphate ; Beryllium phosphate [Beryllium and beryllium compounds]
CAS NO: 13598-15-7
Molecular Formula of Beryllium hydrogen phosphate (1:1) (CAS NO.13598-15-7): HBeO4P
Molecular Weight: 104.9915
Molecular Structure:
H bond acceptors: 4
H bond donors: 3
Freely Rotating Bonds: 0
Polar Surface Area: 76.57 Å2
Boiling Point of Beryllium hydrogen phosphate (1:1) (CAS NO.13598-15-7): 158 °C at 760 mmHg
Vapour Pressure: 1.41 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 16mg/kg (16mg/kg) | Toxicology and Applied Pharmacology. Vol. 24, Pg. 497, 1973. |
NTP 10th Report on Carcinogens. IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 (1972),p. 17.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 23 (1980),p. 143.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Beryllium and its compounds are on the Community Right-To-Know List.
RIDADR: 1566
HazardClass: 6.1(a)
PackingGroup: II
Confirmed carcinogen with experimental carcinogenic and tumorigenic data. Poison by intravenous route. See also BERYLLIUM COMPOUNDS and PHOSPHATES. When heated to decomposition it emits very toxic fumes of BeO and POx.
OSHA PEL: TWA 0.002 mg(Be)/m3; STEL 0.005 mg(Be)/m3/30M; CL 0.025 mg(Be)/m3
ACGIH TLV: TWA 0.002 mg(Be)/m3; Confirmed Human Carcinogen; (Proposed: TWA 0.0002 mg(Be)/m3 (sensitizer); Confirmed Human Carcinogen)
NIOSH REL: (Beryllium) CL not to exceed 0.0005 mg(Be)/m3